Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Silibinin: a novel inhibitor of Aβ aggregation.

Yin F, Liu J, Ji X, Wang Y, Zidichouski J, Zhang J.

Neurochem Int. 2011 Feb;58(3):399-403. doi: 10.1016/j.neuint.2010.12.017.

PMID:
21185897
2.

[An updated review at molecular pharmacological level for the mechanism of anti-tumor, antioxidant and immunoregulatory action of silibinin].

Wang HJ, Jiang YY, Lu P, Wang Q, Ikejima T.

Yao Xue Xue Bao. 2010 Apr;45(4):413-21. Review. Chinese.

PMID:
21355204
3.

Novel drug targets based on metallobiology of Alzheimer's disease.

Bandyopadhyay S, Huang X, Lahiri DK, Rogers JT.

Expert Opin Ther Targets. 2010 Nov;14(11):1177-97. doi: 10.1517/14728222.2010.525352. Review.

PMID:
20942746
4.

Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action.

Borah A, Paul R, Choudhury S, Choudhury A, Bhuyan B, Das Talukdar A, Dutta Choudhury M, Mohanakumar KP.

CNS Neurosci Ther. 2013 Nov;19(11):847-53. doi: 10.1111/cns.12175. Review.

PMID:
24118806
5.

Redox-active metals, oxidative stress, and Alzheimer's disease pathology.

Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT.

Ann N Y Acad Sci. 2004 Mar;1012:153-63. Review.

PMID:
15105262
7.
9.

Novel insights for the treatment of Alzheimer's disease.

Kurz A, Perneczky R.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):373-9. doi: 10.1016/j.pnpbp.2010.07.018. Review.

PMID:
20655969
10.

Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.

Nie Q, Du XG, Geng MY.

Acta Pharmacol Sin. 2011 May;32(5):545-51. doi: 10.1038/aps.2011.14. Review.

11.

Ferulic Acid: A Hope for Alzheimer's Disease Therapy from Plants.

Sgarbossa A, Giacomazza D, di Carlo M.

Nutrients. 2015 Jul 15;7(7):5764-82. doi: 10.3390/nu7075246. Review.

12.

Resveratrol as a therapeutic agent for Alzheimer's disease.

Ma T, Tan MS, Yu JT, Tan L.

Biomed Res Int. 2014;2014:350516. doi: 10.1155/2014/350516. Review.

13.

Alzheimer's disease 2012: the great amyloid gamble.

Marchesi VT.

Am J Pathol. 2012 May;180(5):1762-7. doi: 10.1016/j.ajpath.2012.03.004. Review.

14.

Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease.

Casamenti F, Grossi C, Rigacci S, Pantano D, Luccarini I, Stefani M.

J Alzheimers Dis. 2015;45(3):679-88. doi: 10.3233/JAD-142850. Review.

PMID:
25649656
15.

Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy.

Bosch-Barrera J, Menendez JA.

Cancer Treat Rev. 2015 Jun;41(6):540-6. doi: 10.1016/j.ctrv.2015.04.008. Review.

PMID:
25944486
16.

Biflavonoids as Potential Small Molecule Therapeutics for Alzheimer's Disease.

Thapa A, Chi EY.

Adv Exp Med Biol. 2015;863:55-77. doi: 10.1007/978-3-319-18365-7_3. Review.

PMID:
26092626
17.

Cosmeceuticals and silibinin.

Singh RP, Agarwal R.

Clin Dermatol. 2009 Sep-Oct;27(5):479-84. doi: 10.1016/j.clindermatol.2009.05.012. Review.

18.

Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer.

Ting H, Deep G, Agarwal R.

AAPS J. 2013 Jul;15(3):707-16. doi: 10.1208/s12248-013-9486-2. Review.

19.

The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular).

Rosso N, Marin V, Giordani A, Persiani S, Sala F, Cavicchioli L, Rovati LC, Tiribelli C.

Curr Med Chem. 2015;22(25):2954-71. Review.

PMID:
26219393
20.

Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease.

Kim MH, Kim SH, Yang WM.

Planta Med. 2014 Oct;80(15):1249-58. doi: 10.1055/s-0034-1383038. Review.

PMID:
25210998
Items per page

Supplemental Content

Support Center